VANGUARD GROUP INC 13D and 13G filings for Coya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 3:37 pm Unchanged |
2024-09-30 | 13G | Coya Therapeutics, Inc. COYA |
VANGUARD GROUP INC | 845,424 5.550% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:27 pm Unchanged |
2024-09-30 | 13G | Coya Therapeutics, Inc. COYA |
VANGUARD GROUP INC | 845,424 5.550% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:42 am Purchase |
2024-09-30 | 13G | Coya Therapeutics, Inc. COYA |
VANGUARD GROUP INC | 845,424 5.550% |
845,424 (New Position) |
Filing |